These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3709351)

  • 21. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholics.
    Schottenfeld RS; O'Malley SS; Smith L; Rounsaville BJ; Jaffe JH
    Am J Drug Alcohol Abuse; 1989; 15(3):339-44. PubMed ID: 2669469
    [No Abstract]   [Full Text] [Related]  

  • 23. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
    Rabkin JG; Quitkin FM; McGrath P; Harrison W; Tricamo E
    J Clin Psychopharmacol; 1985 Feb; 5(1):2-9. PubMed ID: 3973068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe daytime somnolence in patients treated with an MAOI.
    Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
    Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mysterious MAOI hypertensive episodes.
    Linet LS
    J Clin Psychiatry; 1986 Nov; 47(11):563-5. PubMed ID: 3095312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study.
    van Haelst IM; van Klei WA; Doodeman HJ; Kalkman CJ; Egberts TC;
    J Clin Psychiatry; 2012 Aug; 73(8):1103-9. PubMed ID: 22938842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAOIs - does the evidence warrant their resurrection?
    Menkes D; Bosanac P; Castle D
    Australas Psychiatry; 2016 Aug; 24(4):371-3. PubMed ID: 26917855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphadenopathy associated with monoamine oxidase inhibitors.
    Kallab AM; Marley EM; Frei-Lahr D
    Am J Hematol; 1999 Feb; 60(2):167. PubMed ID: 9929114
    [No Abstract]   [Full Text] [Related]  

  • 33. On the mechanism of hypotensive effects of MAO inhibitors.
    GESSA GL; CUENCA E; COSTA E
    Ann N Y Acad Sci; 1963 Jul; 107():935-44. PubMed ID: 13947412
    [No Abstract]   [Full Text] [Related]  

  • 34. Degraded protein-containing food and monoamine oxidase inhibitors.
    Lieb J
    Am J Psychiatry; 1977 Dec; 134(12):1444-5. PubMed ID: 920856
    [No Abstract]   [Full Text] [Related]  

  • 35. Seizures in a diabetic patient on monoamine oxidase inhibitors.
    Albareda M; Udina C; Escartín A; Corcoy R
    Am J Emerg Med; 1999 Jan; 17(1):107-8. PubMed ID: 9928719
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoamine oxidase inhibitors and subarachnoid hemorrhage.
    Kundhal PS; Sockalingam S; Krishnadev N; Demarchi R; Bhalerao S
    Can J Psychiatry; 2004 Aug; 49(8):573-4. PubMed ID: 15453109
    [No Abstract]   [Full Text] [Related]  

  • 37. Phenelzine-induced fulminant hepatic failure.
    Gómez-Gil E; Salmerón JM; Mas A
    Ann Intern Med; 1996 Apr; 124(7):692-3. PubMed ID: 8607601
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common side effects associated with monoamine oxidase inhibitors.
    Remick RA; Froese C; Keller FD
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):497-504. PubMed ID: 2748873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine oxidase inhibitors.
    Blackwell B
    Br J Psychiatry; 1986 Feb; 148():216-7. PubMed ID: 3697591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.